Geode Capital Management LLC Decreases Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Geode Capital Management LLC lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,154,157 shares of the company’s stock after selling 3,993 shares during the period. Geode Capital Management LLC’s holdings in Henry Schein were worth $229,196,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Cromwell Holdings LLC lifted its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new stake in shares of Henry Schein during the second quarter valued at $31,000. Blue Trust Inc. increased its position in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after purchasing an additional 1,100 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research reiterated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Seven research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $76.60 on Friday. The business has a 50-day moving average of $72.25 and a two-hundred day moving average of $70.06. The firm has a market capitalization of $9.55 billion, a PE ratio of 31.52, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 EPS. As a group, research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.